Pharmaceutical compositions comprising CBX cannabinoid receptor modulators and Potassium channel modulators

Details for Australian Patent Application No. 2007245733 (hide)

Owner Solvay Pharmaceuticals GmbH

Inventors Lange, Josephus Hubertus Maria; Firnges, Michael; Gregory, Peter-Colin; Antel, Jochen; Reiche, Dania

Agent Watermark

Pub. Number AU-A-2007245733

PCT Pub. Number WO2007/125048

Priority 06113188.4 27.04.06 EP

Filing date 20 April 2007

Wipo publication date 8 November 2007

International Classifications

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/045 (2006.01) - Hydroxy compounds, e.g. alcohols

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

18 December 2008 PCT application entered the National Phase

  PCT publication WO2007/125048 Priority application(s): WO2007/125048

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007245734-Use of CBX cannabinoid receptor modulators as potassium channel modulators

2007245732-Gasification reactor and its use